Cytel Releases elements™ - A New Clinical Trial Design and Analysis Toolkit
Next generation software line handles both trial design and data analysis of clinical pharmacology and bioequivalence studies critical to clinical development success
Cambridge, MA, August 03, 2008 - Cytel Inc., a leading provider of clinical trial design services and specialized statistical software, today announced the release of elements™, a comprehensive, fully validated, design and analysis toolkit for clinical pharmacology trials and bioequivalence studies. With unrivaled accuracy and efficiency, elements™generates trial designs and analyses to speed the design assessment process crucial to selecting the trial approach with the greatest chance of success.
Rigorously tested and validated in accordance with FDA and CPMP guidelines, elements™ is the result of a dedicated effort by Cytel's teams of biostatistics and algorithm developers, in consultation with leading experts from the international pharmaceutical and biotechnology industry. Delivering fast and reliable results, elements™ users quickly explore and determine viable trial design parameters, and generate required regulatory documentation.
"In elements™ we've created a truly intuitive, easily understood interface that simplifies the routines of clinical trial planning," said Product Manager and Senior Statistician Yannis Jemiai, PhD. "elements™ uniquely addresses the needs of early stage statisticians and scientists by bringing together the necessary design, analysis, and reporting tools for pharmacology and bioequivalence trials."
This important release introduces a new generation of Cytel software designed to boost clinical productivity by simplifying and automating the statistical design and analysis of study data, while also providing adaptive trial decision tools.
Designed for trial planners in the pharmaceutical, biotech, and generics industries, elements™ is available immediately. For more information about including licensing and training options, contact Cytel directly at +1.617.661.2011 or sales@cytel.com
About Cytel
Cytel Inc. is a leading provider of clinical trial design services and specialized statistical software for the biopharmaceutical, medical device, academic, and government research markets. Cytel’s East® system is used at hundreds of commercial sites, throughout academia, and by regulators to design, simulate and monitor adaptive and group sequential clinical trials. Cytel provides trial sponsors with innovative tools, training and consultation to increase the return on investment in clinical development.
For interview requests, product images or information, contact:
Michael Weitz
Marketing Director
617.661.2011
mike@cytel.com